Viewing Study NCT02971969


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-25 @ 8:49 PM
Study NCT ID: NCT02971969
Status: COMPLETED
Last Update Posted: 2022-01-06
First Post: 2016-11-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B
Sponsor: Ultragenyx Pharmaceutical Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module References Module